These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

267 related articles for article (PubMed ID: 22283765)

  • 21. Schizophrenia and the parvalbumin-containing class of cortical local circuit neurons.
    Woo TU; Miller JL; Lewis DA
    Am J Psychiatry; 1997 Jul; 154(7):1013-5. PubMed ID: 9210755
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Decreased glutamic acid decarboxylase67 messenger RNA expression in a subset of prefrontal cortical gamma-aminobutyric acid neurons in subjects with schizophrenia.
    Volk DW; Austin MC; Pierri JN; Sampson AR; Lewis DA
    Arch Gen Psychiatry; 2000 Mar; 57(3):237-45. PubMed ID: 10711910
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Decreased dendritic spine density on prefrontal cortical pyramidal neurons in schizophrenia.
    Glantz LA; Lewis DA
    Arch Gen Psychiatry; 2000 Jan; 57(1):65-73. PubMed ID: 10632234
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Measurement of GABAergic parameters in the prefrontal cortex in schizophrenia: focus on GABA content, GABA(A) receptor alpha-1 subunit messenger RNA and human GABA transporter-1 (HGAT-1) messenger RNA expression.
    Ohnuma T; Augood SJ; Arai H; McKenna PJ; Emson PC
    Neuroscience; 1999; 93(2):441-8. PubMed ID: 10465426
    [TBL] [Abstract][Full Text] [Related]  

  • 25. GABA neuron alterations, cortical circuit dysfunction and cognitive deficits in schizophrenia.
    Gonzalez-Burgos G; Fish KN; Lewis DA
    Neural Plast; 2011; 2011():723184. PubMed ID: 21904685
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Perisomatic inhibition and cortical circuit dysfunction in schizophrenia.
    Lewis DA; Fish KN; Arion D; Gonzalez-Burgos G
    Curr Opin Neurobiol; 2011 Dec; 21(6):866-72. PubMed ID: 21680173
    [TBL] [Abstract][Full Text] [Related]  

  • 27. GABA
    Hong T; Falcone C; Dufour B; Amina S; Castro RP; Regalado J; Pearson W; Noctor SC; Martínez-Cerdeño V
    Neuroscience; 2020 Jun; 437():76-86. PubMed ID: 32335215
    [TBL] [Abstract][Full Text] [Related]  

  • 28. GABAergic dysfunction in schizophrenia: new treatment strategies on the horizon.
    Guidotti A; Auta J; Davis JM; Dong E; Grayson DR; Veldic M; Zhang X; Costa E
    Psychopharmacology (Berl); 2005 Jul; 180(2):191-205. PubMed ID: 15864560
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Early developmental disturbances of cortical inhibitory neurons: contribution to cognitive deficits in schizophrenia.
    Volk DW; Lewis DA
    Schizophr Bull; 2014 Sep; 40(5):952-7. PubMed ID: 25053651
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pathophysiologically based treatment interventions in schizophrenia.
    Lewis DA; Gonzalez-Burgos G
    Nat Med; 2006 Sep; 12(9):1016-22. PubMed ID: 16960576
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Postnatal development of prefrontal inhibitory circuits and the pathophysiology of cognitive dysfunction in schizophrenia.
    Lewis DA; Cruz D; Eggan S; Erickson S
    Ann N Y Acad Sci; 2004 Jun; 1021():64-76. PubMed ID: 15251876
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prefrontal cortical gamma-aminobutyric acid transmission and cognitive function: drawing links to schizophrenia from preclinical research.
    Tse MT; Piantadosi PT; Floresco SB
    Biol Psychiatry; 2015 Jun; 77(11):929-39. PubMed ID: 25442792
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Transcriptional dysregulation of γ-aminobutyric acid transporter in parvalbumin-containing inhibitory neurons in the prefrontal cortex in schizophrenia.
    Bitanihirwe BK; Woo TU
    Psychiatry Res; 2014 Dec; 220(3):1155-9. PubMed ID: 25312391
    [TBL] [Abstract][Full Text] [Related]  

  • 34. GABA transporter-1 mRNA in the prefrontal cortex in schizophrenia: decreased expression in a subset of neurons.
    Volk D; Austin M; Pierri J; Sampson A; Lewis D
    Am J Psychiatry; 2001 Feb; 158(2):256-65. PubMed ID: 11156808
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Altered Gradients of Glutamate and Gamma-Aminobutyric Acid Transcripts in the Cortical Visuospatial Working Memory Network in Schizophrenia.
    Hoftman GD; Dienel SJ; Bazmi HH; Zhang Y; Chen K; Lewis DA
    Biol Psychiatry; 2018 Apr; 83(8):670-679. PubMed ID: 29357982
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Markers of glutamate and GABA neurotransmission in the prefrontal cortex of schizophrenia subjects: Disease effects differ across anatomical levels of resolution.
    Dienel SJ; Enwright JF; Hoftman GD; Lewis DA
    Schizophr Res; 2020 Mar; 217():86-94. PubMed ID: 31296415
    [TBL] [Abstract][Full Text] [Related]  

  • 37. GABAergic inhibitory neurons as therapeutic targets for cognitive impairment in schizophrenia.
    Xu MY; Wong AHC
    Acta Pharmacol Sin; 2018 May; 39(5):733-753. PubMed ID: 29565038
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Conserved regional patterns of GABA-related transcript expression in the neocortex of subjects with schizophrenia.
    Hashimoto T; Bazmi HH; Mirnics K; Wu Q; Sampson AR; Lewis DA
    Am J Psychiatry; 2008 Apr; 165(4):479-89. PubMed ID: 18281411
    [TBL] [Abstract][Full Text] [Related]  

  • 39. GABA Targets for the Treatment of Cognitive Dysfunction in Schizophrenia.
    Volk DW; Lewis DA
    Curr Neuropharmacol; 2005 Jan; 3(1):45-62. PubMed ID: 22545031
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Functional and anatomical aspects of prefrontal pathology in schizophrenia.
    Goldman-Rakic PS; Selemon LD
    Schizophr Bull; 1997; 23(3):437-58. PubMed ID: 9327508
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.